360 related articles for article (PubMed ID: 8591891)
1. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats.
Liu YH; Yang XP; Sharov VG; Sigmon DH; Sabbath HN; Carretero OA
Hypertension; 1996 Jan; 27(1):7-13. PubMed ID: 8591891
[TBL] [Abstract][Full Text] [Related]
2. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
Hartman JC
Ann Thorac Surg; 1995 Sep; 60(3):789-92. PubMed ID: 7545893
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide.
Ehring T; Baumgart D; Krajcar M; Hümmelgen M; Kompa S; Heusch G
Circulation; 1994 Sep; 90(3):1368-85. PubMed ID: 8087948
[TBL] [Abstract][Full Text] [Related]
4. Synergy of amlodipine and angiotensin-converting enzyme inhibitors in regulating myocardial oxygen consumption in normal canine and failing human hearts.
Mital S; Loke KE; Slater JP; Addonizio L; Gersony WM; Hintze TH
Am J Cardiol; 1999 Jun; 83(12A):92H-98H. PubMed ID: 10750596
[TBL] [Abstract][Full Text] [Related]
5. Apstatin, a selective inhibitor of aminopeptidase P, reduces myocardial infarct size by a kinin-dependent pathway.
Wolfrum S; Richardt G; Dominiak P; Katus HA; Dendorfer A
Br J Pharmacol; 2001 Sep; 134(2):370-4. PubMed ID: 11564655
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment with ramiprilat induces cardioprotection against free radical injury in guinea-pig isolated heart: involvement of bradykinin, protein kinase C and prostaglandins.
Jin ZQ; Chen X
Clin Exp Pharmacol Physiol; 2000 Apr; 27(4):257-62. PubMed ID: 10779122
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of nitric oxide synthase prevents myocardial protection by ramiprilat.
Hartman JC; Kurc GM; Hullinger TG; Wall TM; Sheehy RM; Shebuski RJ
J Pharmacol Exp Ther; 1994 Sep; 270(3):1071-6. PubMed ID: 7523655
[TBL] [Abstract][Full Text] [Related]
8. Coronary vasodilation induced by angiotensin-converting enzyme inhibition in vivo: differential contribution of nitric oxide and bradykinin in conductance and resistance arteries.
Sudhir K; Chou TM; Hutchison SJ; Chatterjee K
Circulation; 1996 May; 93(9):1734-9. PubMed ID: 8653880
[TBL] [Abstract][Full Text] [Related]
9. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation.
Farhy RD; Carretero OA; Ho KL; Scicli AG
Circ Res; 1993 Jun; 72(6):1202-10. PubMed ID: 7684331
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotective effect of angiotensin-converting enzyme inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes.
Matoba S; Tatsumi T; Keira N; Kawahara A; Akashi K; Kobara M; Asayama J; Nakagawa M
Circulation; 1999 Feb; 99(6):817-22. PubMed ID: 9989969
[TBL] [Abstract][Full Text] [Related]
11. Kinins or nitric oxide, or both, are involved in the antitrophic effects of angiotensin converting enzyme inhibitors on diabetes-associated mesenteric vascular hypertrophy in the rat.
Rumble JR; Komers R; Cooper ME
J Hypertens; 1996 May; 14(5):601-7. PubMed ID: 8762203
[TBL] [Abstract][Full Text] [Related]
12. Reduction of myocardial infarct size by ramiprilat is independent of angiotensin II synthesis inhibition.
Hartman JC; Hullinger TG; Wall TM; Shebuski RJ
Eur J Pharmacol; 1993 Apr; 234(2-3):229-36. PubMed ID: 8482328
[TBL] [Abstract][Full Text] [Related]
13. Reduction of myocardial infarct size in rabbits by ramiprilat: reversal by the bradykinin antagonist HOE 140.
Hartman JC; Wall TM; Hullinger TG; Shebuski RJ
J Cardiovasc Pharmacol; 1993 Jun; 21(6):996-1003. PubMed ID: 7687728
[TBL] [Abstract][Full Text] [Related]
14. Role of Ca2+-activated K+ channels in the protective effect of ACE inhibition against ischemic myocardial injury.
Node K; Kitakaze M; Kosaka H; Minamino T; Mori H; Hori M
Hypertension; 1998 Jun; 31(6):1290-8. PubMed ID: 9622144
[TBL] [Abstract][Full Text] [Related]
15. Cardioprotection with angiotensin converting enzyme inhibitor and angiotensin II type 1 receptor antagonist is not abolished by nitric oxide synthase inhibitor in ischemia-reperfused rabbit hearts.
Kawabata H; Ryomoto T; Ishikawa K
Hypertens Res; 2001 Jul; 24(4):403-9. PubMed ID: 11510753
[TBL] [Abstract][Full Text] [Related]
16. Local inhibition of bradykinin degradation in ischemic hearts.
Linz W; Martorana PA; Schölkens BA
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
[TBL] [Abstract][Full Text] [Related]
17. Vasopeptidase inhibitor omapatrilat induces profound insulin sensitization and increases myocardial glucose uptake in Zucker fatty rats: Studies comparing a vasopeptidase inhibitor, angiotensin-converting enzyme inhibitor, and angiotensin II type I receptor blocker.
Wang CH; Leung N; Lapointe N; Szeto L; Uffelman KD; Giacca A; Rouleau JL; Lewis GF
Circulation; 2003 Apr; 107(14):1923-9. PubMed ID: 12668518
[TBL] [Abstract][Full Text] [Related]
18. Effect of neutral endopeptidase 24.11 inhibition on myocardial ischemia/reperfusion injury: the role of kinins.
Yang XP; Liu YH; Peterson E; Carretero OA
J Cardiovasc Pharmacol; 1997 Feb; 29(2):250-6. PubMed ID: 9057075
[TBL] [Abstract][Full Text] [Related]
19. Postischemic antiarrhythmic effects of angiotensin-converting enzyme inhibitors. Role of suppression of endogenous endothelin secretion.
Brunner F; Kukovetz WR
Circulation; 1996 Oct; 94(7):1752-61. PubMed ID: 8840871
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of epinephrine-induced dysrhythmias by bradykinin: role of nitric oxide and prostaglandins.
Rajani V; Hussain Y; Bolla BS; de Guzman FQ; Montiague RR; Igić R; Rabito SF
Am J Cardiol; 1997 Aug; 80(3A):153A-157A. PubMed ID: 9293970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
